Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: Maternal diets rich in indole-3-carbinol versus sulforaphane

Toxicology and Applied Pharmacology

Volumn 270, Issue 1, 2013, Pages 60-69

  Shorey, Lyndsey E ^a,b   Madeen, Erin P ^a,b   Atwell, Lauren L ^a,b   Ho, Emily ^a,b   Löhr, Christiane V ^a,b   Pereira, Clifford B ^a   Dashwood, Roderick H ^a,b   Williams, David E ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

Indole 3 carbinol; Polycyclic aromatic hydrocarbon; Sulforaphane; T cell lymphoblastic lymphoma; Transplacental

Indexed keywords

3 INDOLEMETHANOL; CHRYSENE DERIVATIVE; DIBENZO[DEF P]CHRYSENE; DRUG METABOLITE; SULFORAPHANE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BROCCOLI; BRUSSELS SPROUT; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LACTATION; LUNG TUMOR; LYMPHOBLASTOMA; MALE; MATERNAL NUTRITION; MORBIDITY; MOUSE; NEWBORN; NONHUMAN; SURVIVAL; TRANSPLACENTAL CARCINOGENESIS;

ANIMALS; ANTICARCINOGENIC AGENTS; BENZOPYRENES; CARCINOGENS; DIET; FEMALE; INDOLES; LUNG NEOPLASMS; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MATERNAL-FETAL EXCHANGE; MICE; MICE, 129 STRAIN; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREGNANCY; THIOCYANATES;

EID: 84877351328     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.02.016     Document Type: Article

References (69)

1. Anderson L.M., Jones A.B., Riggs C.W., Ohshima M. Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis 1985, 6:1389-1393.
2. Anderson L.M., Ruskie S., Carter J., Pittinger S., Kovatch R.M., Riggs C.W. Fetal mouse susceptibility to transplacental carcinogenesis: differential influence of Ah receptor phenotype on effects of 3-methylcholanthrene, 7,12-dimethylbenz[a]anthracene, and benzo[a]pyrene. Pharmacogenetics 1995, 5:364-372.
3. Aronchik I., Bjeldanes L.F., Firestone G.L. Direct inhibition of elastase activity by indole-3-carbinol triggers a CD40-TRAF regulatory cascade that disrupts NF-kappaB transcriptional activity in human breast cancer cells. Cancer Res. 2010, 70:4961-4971.
4. Bosetti C., Filomeno M., Riso P., Polesel J., Levi F., Talamini R., Montella M., Negri E., Franceschi S., La Vecchia C. Cruciferous vegetables and cancer risk in a network of case-control studies. Annals Oncol. 2012, 23:2198-2203.
5. Bradlow H.L. Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In Vivo 2008, 22:441-445.
6. Buters J.T., Mahadevan B., Quintanilla-Martinez L., Gonzalez F.J., Greim H., Baird W.M., Luch A. Cytochrome P450 1B1 determines susceptibility to dibenzo[a, l]pyrene-induced tumor formation. Chem. Res. Toxicol. 2002, 15:1127-1135.
7. Calkins K., Devaskar S.U. Fetal origins of adult disease. Curr. Prob. Pediat. Adolesc. Hlth. Care 2011, 41:158-176.
8. Castro D.J., Baird W.M., Pereira C.B., Giovanini J., Löhr C.V., Fischer K.A., Yu Z., Gonzalez F.J., Krueger S.K., Williams D.E. Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a, l)pyrene. Cancer Prev. Res. 2008, 1:128-134.
9. Castro D.J., Yu Z., Löhr C.V., Pereira C.B., Giovanini J.N., Fischer K.A., Orner G.A., Dashwood R.H., Williams D.E. Chemoprevention of dibenzo[a, l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine. Carcinogenesis 2008, 29:1581-1586.
10. Castro D.J., Löhr C.V., Fischer K.A., Pereira C.B., Williams D.E. Lymphoma and lung cancer in offspring born to pregnant mice dosed with dibenzo[a,l]pyrene: the importance of in utero vs. lactational exposure. Toxicol. Appl. Pharmacol. 2008, 233:454-458.
11. Castro D.J., Löhr C.V., Fischer K.A., Waters K.M., Webb-Robertson B.J., Dashwood R.H., Bailey G.S., Williams D.E. Identifying efficacious approaches to chemoprevention with chlorophyllin, purified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesis. Carcinogenesis 2009, 30:315-320.
12. Cavalieri E.L., Higginbotham S., RamaKrishna N.V., Devanesan P.D., Todorovic R., Rogan E.G., Salmasi S. Comparative dose-response tumorigenicity studies of dibenzo[a, l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and two dibenzo[a, l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 1991, 12:1939-1944.
13. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 2005, 436:50-61.
14. Clarke J.D., Dashwood R.H., Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008, 269:291-304.
15. Clarke J.D., Hsu A., Williams D.E., Dashwood R.H., Stevens J.F., Yamamoto M., Ho E. Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm. Res. 2011, 28:3171-3179.
16. Conaway C.C., Getahun S.M., Liebes L.L., Pusateri D.J., Topham D.K., Botero-Omary M., Chung F.L. Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer 2000, 38:168-178.
17. Davis C.D., Zeng H., Finley J.W. Selenium-enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J. Nutr. 2002, 132:307-309.
18. Fahey J.W., Zhang Y., Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10367-10372.
19. Fang C., Zhang Q.Y. The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyrene. J. Pharmacol. Exptl. Therap. 2010, 334:156-163.
20. Fimognari C., Turrini E., Ferruzzi L., Lenzi M., Hrelia P. Natural isothiocyanates: genotoxic potential versus chemoprevention. Mutat. Res. 2011, 750:107-131.
21. Gerk P.M., Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J. Pharmcol. Exptl. Therap. 2002, 302:407-415.
22. Hanlon N., Coldham N., Gielbert A., Kuhnert N., Sauer M.J., King L.J., Ioannides C. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat. Br. J. Nutr. 2008, 99:559-564.
23. Hayes J.D., Kelleher M.O., Eggleston I.M. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur. J. Nutr. 2008, 47(Suppl. 2):73-88.
24. Heidel S.M., MacWilliams P.S., Baird W.M., Dashwood W.M., Buters J.T., Gonzalez F.J., Larsen M.C., Czuprynski C.J., Jefcoate C.R. Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res. 2000, 60:3454-3460.
25. Ho E., Clarke J.D., Dashwood R.H. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J. Nutr. 2009, 139:2393-2396.
26. Hwang E.S., Jeffery E.H. Effects of different processing methods on induction of quinone reductase by dietary broccoli in rats. J. Med. Food 2004, 7:95-99.
27. IARC Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr. Eval. Carcinog. Risks Hum. Suppl. 2010, 92:1-853.
28. Kalpana Deepa Priya D., Gayathri R., Sakthisekaran D. Role of sulforaphane in the anti-initiating mechanism of lung carcinogenesis in vivo by modulating the metabolic activation and detoxification of benzo(a)pyrene. Biomed. Pharmacother. 2011, 65:9-16.
29. Kassie F., Matise I., Negia M., Upadhyaya P., Hecht S.S. Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev. Res. 2008, 1:568-576.
30. Kerns M.L., DePianto D., Dinkova-Kostova A.T., Talalay P., Coulombe P.A. Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14460-14465.
31. Keum Y.S., Khor T.O., Lin W., Shen G., Kwon K.H., Barve A., Li W., Kong A.N. Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway. Pharm. Res. 2009, 26:2324-2331.
32. Liu A.G., Volker S.E., Jeffery E.H., Erdman J.W. Feeding tomato and broccoli powders enriched with bioactives improves bioactivity markers in rats. J. Agric. Food Chem. 2009, 57:7304-7310.
33. Luch A., Platt K.L., Seidel A. Synthesis of fjord region tetraols and their use in hepatic biotransformation studies of dihydrodiols of benzo[c]chrysene, benzo[g]chrysene and dibenzo[a, l]pyrene. Carcinogenesis 1998, 19:639-648.
34. Matusheski N.V., Jeffery E.H. Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J. Agric. Food Chem. 2001, 49:5743-5749.
35. Miller M.S., Leone-Kabler S., Rollins L.A., Wessner L.L., Fan M., Schaeffer D.O., McEntee M.F., O'Sullivan M.G. Molecular pathogenesis of transplacentally induced mouse lung tumors. Exptl. Lung Res. 1998, 24:557-577.
36. Miyata M., Furukawa M., Takahashi K., Gonzalez F.J., Yamazoe Y. Mechanism of 7,12-dimethylbenz[a]anthracene-induced immunotoxicity: role of metabolic activation at the target organ. Jpn. J. Pharmacol. 2001, 86:302-309.
37. Myzak M.C., Karplus P.A., Chung F.L., Dashwood R.H. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 2004, 64:5767-5774.
38. Nakamura B.N., Mohar I., Lawson G.W., Cortes M.M., Hoang Y.D., Ortiz L., Patel R., Rau B.A., McConnachie L.A., Kavanagh T.J., Luderer U. Increased sensitivity to testicular toxicity of transplacental benzo[a]pyrene exposure in male glutamate cysteine ligase modifier subunit knockout (Gclm-/-) mice. Toxicol. Sci. 2012, 126:227-241.
39. NCI SEER Cancer Statistics Review, 1975-2008 2011, National Cancer Institute, Bethesda, MD.
40. Noyan-Ashraf M.H., Wu L., Wang R., Juurlink B.H.J. Dietary approaches to positively influence fetal determinants of adult health. FASEB J. 2005, 20:371-373.
41. Pappa G., Bartsch H., Gerhauser C. Biphasic modulation of cell proliferation by sulforaphane at physiologically relevant exposure times in a human colon cancer cell line. Mol. Nutr. Food Res. 2007, 51:977-984.
42. Park J.Y., Bjeldanes L.F. Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo[a]pyrene to hepatic and pulmonary DNA in the rat. Chem. Biol. Interact. 1992, 83:235-247.
43. Platt K.L., Dienes H.P., Tommasone M., Luch A. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def, p]chrysene (dibenzo[a, l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol. Chem. Biol. Interact. 2004, 148:27-36.
44. Prahalad A.K., Ross J.A., Nelson G.B., Roop B.C., King L.C., Nesnow S., Mass M.J. Dibenzo[a, l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis 1997, 18:1955-1963.
45. Priya D.K., Gayathri R., Gunassekaran G., Murugan S., Sakthisekaran D. Chemopreventive role of sulforaphane by upholding the GSH redox cycle in pre- and post-initiation phases of experimental lung carcinogenesis. Asian Pacif. J. Cancer Prev. 2011, 12:103-110.
46. Priya D.K., Gayathri R., Gunassekaran G.R., Sakthisekaran D. Protective role of sulforaphane against oxidative stress mediated mitochondrial dysfunction induced by benzo(a)pyrene in female Swiss albino mice. Pulmon. Pharmacol. Therapeut. 2011, 24:110-117.
47. Ramesh A., Walker S.A., Hood D.B., Guillen M.D., Schneider K., Weyand E.H. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Internatl. J. Toxicol. 2004, 23:301-333.
48. Reed G.A., Arneson D.W., Putnam W.C., Smith H.J., Gray J.C., Sullivan D.K., Mayo M.S., Crowell J.A., Hurwitz A. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2477-2481.
49. Richman E.L., Carroll P.R., Chan J.M. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Internatl. J. Cancer 2012, 131:201-210.
50. Sarkar F.H., Li Y., Wang Z., Kong D. Cellular signaling perturbation by natural products. Cell. Signl. 2009, 21:1541-1547.
51. Saw C.L., Cintron M., Wu T.Y., Guo Y., Huang Y., Jeong W.S., Kong A.N. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharmaceut. Drug Dispos. 2011, 32:289-300.
52. Shi Z., Dragin N., Galvez-Peralta M., Jorge-Nebert L.F., Miller M.L., Wang B., Nebert D.W. Organ-specific roles of CYP1A1 during detoxication of dietary benzo[a]pyrene. Molec. Pharmacol. 2010, 78:46-57.
53. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metabol. Pharmacokin. 2006, 21:257-276.
54. Shorey L.E., Castro D.J., Baird W.M., Siddens L.K., Löhr C.V., Matzke M.M., Waters K.M., Corley R.A., Williams D.E. Transplacental carcinogenesis with dibenzo[def, p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring. Cancer Lett. 2012, 317:49-55.
55. Siddens L.K., Larkin A., Krueger S.K., Bradfield C.A., Waters K.M., Tilton S.C., Pereira C.B., Löhr C.V., Arlt V.M., Phillips D.H., Williams D.E., Baird W.M. Polycyclic aromatic hydrocarbons as skin carcinogens: comparison of benzo[a]pyrene, dibenzo[def, p]chrysene and three environmental mixtures in the FVB/N mouse. Toxicol. Appl. Pharmacol. 2012, 264:377-386.
56. Skupinska K., Misiewicz-Krzeminska I., Lubelska K., Kasprzycka-Guttman T. The effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells. Toxicol In Vitro 2009, 23:763-771.
57. Skupinska K., Misiewicz-Krzeminska I., Stypulkowski R., Lubelska K., Kasprzycka-Guttman T. Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene. J. Biochem. Molec. Toxicol. 2009, 23:18-28.
58. Steinkellner H., Rabot S., Freywald C., Nobis E., Scharf G., Chabicovsky M., Knasmuller S., Kassie F. Effects of cruciferous vegetables and their constituents on drug metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. Mutat. Res. 2001, 480-481:285-297.
59. Stresser D.M., Williams D.E., Griffin D.A., Bailey G.S. Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metabol Dispos 1995, 23:965-975.
60. Swinney R.M., Beuten J., Collier A.B., Chen T.T., Winick N.J., Pollock B.H., Tomlinson G.E. Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children. Cancer Epidemiol. Biomarkers Prev. 2011, 20:1537-1542.
61. Uno S., Dalton T.P., Derkenne S., Curran C.P., Miller M.L., Shertzer H.G., Nebert D.W. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Molec. Pharmacol. 2004, 65:1225-1237.
62. Uno S., Dalton T.P., Dragin N., Curran C.P., Derkenne S., Miller M.L., Shertzer H.G., Gonzalez F.J., Nebert D.W. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Molec. Pharmacol. 2006, 69:1103-1114.
63. Vijayakrishnan J., Houlston R.S. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematol. 2010, 95:1405-1414.
64. Weng J.R., Tsai C.H., Kulp S.K., Chen C.S. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008, 262:153-163.
65. Whyatt R.M., Jedrychowski W., Hemminki K., Santella R.M., Tsai W.Y., Yang K., Perera F.P. Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. Cancer Epidemiol. Biomarkers Prev. 2001, 10:581-588.
66. Yu Z., Loehr C.V., Fischer K.A., Louderback M.A., Krueger S.K., Dashwood R.H., Kerkvliet N.I., Pereira C.B., Jennings-Gee J.E., Dance S.T., Miller M.S., Bailey G.S., Williams D.E. In utero exposure of mice to dibenzo[a, l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res. 2006, 66:755-762.
67. Yu Z., Mahadevan B., Löhr C.V., Fischer K.A., Louderback M.A., Krueger S.K., Pereira C.B., Albershardt D.J., Baird W.M., Bailey G.S., Williams D.E. Indole-3-carbinol in the maternal diet provides chemoprotection for the fetus against transplacental carcinogenesis by the polycyclic aromatic hydrocarbon dibenzo[a, l]pyrene. Carcinogenesis 2006, 27:2116-2123.
68. Zhang Y., Talalay P., Cho C.G., Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:2399-2403.
69. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3147-3150.